SCHEMBL4906202

SCHEMBL4906202

CCN(Sc1ccc(-c2ccccc2)nn1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.44
NPC1 O15118 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 6/20 0.41
TSHR P16473 2/20 0.41
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
RXFP1 Q9HBX9 1/20 0.38
HPGD P15428 5/20 0.38
LMNA P02545 3/20 0.38
HCRTR1 O43613 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PKM P14618 1/20 0.38
MAPT P10636 6/20 0.37
MAPK1 P28482 1/20 0.36
SLC12A2 P55011 1/20 0.36
SLC12A5 Q9H2X9 1/20 0.36
KDM4E B2RXH2 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4894579 0.91 NPC1 (0.41) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL4902616 0.90 RXFP1 (0.37) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL4902449 0.84 TSHR (0.44) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL4905834 0.82 MAPT (0.39) RAB9ANPC1SMN1; SMN2ALDH1A1CA1
SCHEMBL4906189 0.79 LMNA (0.45) RAB9ANPC1SMN1; SMN2ALDH1A1TSHR
SCHEMBL4906163 0.78 KMT2A (0.44) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL4905953 0.78 ALDH1A1 (0.46) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL4902656 0.78 LMNA (0.44) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL4900555 0.76 ALDH1A1 (0.41) RAB9ANPC1SMN1; SMN2KMT2AMEN1
SCHEMBL4905613 0.76 ALDH1A1 (0.48) RAB9ANPC1SMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD RAB9A 2581/4885NPC1 50/4885SMN1; SMN2 3271/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD RAB9A 2271/4885NPC1 59/4885SMN1; SMN2 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.